Intensive Care Unit-Specific Virtual Reality for Critically Ill Patients With COVID-19: Multicenter Randomized Controlled Trial

被引:0
|
作者
Vlake, Johan H. [1 ,2 ]
van Bommel, Jasper [1 ]
Wils, Evert-Jan [2 ]
Bienvenu, Joe [3 ]
Hellemons, Merel E. [4 ]
Korevaar, Tim I. M. [5 ]
Schut, Anna F. C. [6 ]
Labout, Joost A. M. [7 ]
Schreuder, Lois L. H. [1 ]
van Bavel, Marten P. [1 ]
Gommers, Diederik [1 ]
van Genderen, Michel E. [1 ]
机构
[1] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands
[2] Franciscus Gasthuis & Vlietland, Dept Intens Care, Rotterdam, Netherlands
[3] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD USA
[4] Erasmus MC, Dept Pulmonol, Rotterdam, Netherlands
[5] Erasmus MC, Acad Ctr Thyroid Dis, Dept Internal Med, Rotterdam, Netherlands
[6] Ikazia Hosp, Dept Intens Care, Rotterdam, Netherlands
[7] Maasstad Hosp, Dept Intens Care, Rotterdam, Netherlands
关键词
SARS-CoV-2; intensive care; post-intensive care syndrome; virtual reality; quality of life; satisfaction; COVID-19; POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; SHORT-FORM; 36; HOSPITAL ANXIETY; CRITICAL ILLNESS; DEPRESSION SCALE; EVENT SCALE; AFTER-DISCHARGE; HEALTH SURVEY; SURVIVORS;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Although psychological sequelae after intensive care unit (ICU) treatment are considered quite intrusive, robustly effective interventions to treat or prevent these long-term sequelae are lacking. Recently, it was demonstrated that ICU-specific virtual reality (ICU-VR) is a feasible and acceptable intervention with potential mental health benefits. However, its effect on mental health and ICU aftercare in COVID-19 ICU survivors is unknown. Objective: This study aimed to explore the effects of ICU-VR on mental health and on patients' perceived quality of, satisfaction with, and rating of ICU aftercare among COVID-19 ICU survivors. Methods: This was a multicenter randomized controlled trial. Patients were randomized to either the ICU-VR (intervention) or the control group. All patients were invited to an COVID-19 post-ICU follow-up clinic 3 months after hospital discharge, during which patients in the intervention group received ICU-VR. One month and 3 months later (4 and 6 months after hospital discharge), mental health, quality of life, perceived quality, satisfaction with, and rating of ICU aftercare were scored using questionnaires. Results: Eighty-nine patients (median age 58 years; 63 males, 70%) were included. The prevalence and severity of psychological distress were limited throughout follow-up, and no differences in psychological distress or quality of life were observed between the groups. ICU-VR improved satisfaction with (mean score 8.7, SD 1.6 vs 7.6, SD 1.6 [ICU-VR vs control]; t64=-2.82, P=.006) and overall rating of ICU aftercare (mean overall rating of aftercare 8.9, SD 0.9 vs 7.8, SD 1.7 [ICU-VR vs control]; t64=-3.25; P=.002) compared to controls. ICU-VR added to the quality of ICU aftercare according to 81% of the patients, and all patients would recommend ICU-VR to other ICU survivors. Conclusions: ICU-VR is a feasible and acceptable innovative method to improve satisfaction with and rating of ICU aftercare and adds to its perceived quality. We observed a low prevalence of psychological distress after ICU treatment for COVID-19, and ICU-VR did not improve psychological recovery or quality of life. Future research is needed to confirm our results in other critical illness survivors to potentially facilitate ICU-VR's widespread availability and application during follow-up.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Evaluation of the effectiveness of the modified nutrition risk in the critically ill (mNUTRIC) score in critically ill patients affected by COVID-19 admitted to the intensive care unit (ICU)
    Alikiaii, Babak
    Hashemi, Seyed Taghi
    Kiani, Zahra
    Heidari, Zahra
    Nazemroaya, Behzad
    Golparvar, Mohammad
    Daneshmanesh, Somayyeh
    Fattahpour, Shirin
    Amini, Sepide
    Shojaei, Mehrnaz
    Bagherniya, Mohammad
    BMC NUTRITION, 2022, 8 (01)
  • [32] Effect of Hemadsorption Therapy in Critically Ill Patients with COVID-19 (CYTOCOV-19): A Prospective Randomized Controlled Pilot Trial
    Jarczak, Dominik
    Roedl, Kevin
    Fischer, Marlene
    de Heer, Geraldine
    Burdelski, Christoph
    Frings, Daniel Peter
    Sensen, Barbara
    Boenisch, Olaf
    Tariparast, Pischtaz Adel
    Kluge, Stefan
    Nierhaus, Axel
    BLOOD PURIFICATION, 2023, 52 (02) : 183 - 192
  • [33] Informed Consent In Multicenter Randomized Controlled Trial On Nutrition In Critically Ill Patients
    Sadat, M.
    Afesh, L.
    Brown, M.
    Watpool, I.
    Reddie, S.
    Sohail, M.
    Al Moammar, T.
    Jones, G.
    Mehta, S.
    Mclntyre, L.
    Sulaiman, O.
    Haddad, S.
    Arabi, Y. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [34] Practical aspects of intensive care for critically ill COVID-19 patients requiring respiratory support
    Vegh Tamas
    Laszlo Istvan
    Juhasz Marianna
    Berhes Mariann
    Fabian Akos
    Koszta Gyorgy
    Molnar Csilla
    Fulesdi Bela
    ORVOSI HETILAP, 2020, 161 (17) : 678 - 684
  • [35] Cytokine absorption in critically ill old COVID-19 patients with renal failure: A retrospective analysis of 503 intensive care unit patients
    Binneboessel, Stephan
    Bruno, Raphael Romano
    Wernly, Bernhard
    Masyuk, Maryna
    Flaatten, Hans
    Fjolner, Jesper
    Wolff, Georg
    Kelm, Malte
    Beil, Michael
    Sviri, Sigal
    Szczeklik, Wojciech
    Leaver, Susannah
    De Lange, Dylan W.
    Guidet, Bertrand
    Jung, Christian
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2023, 85 (02) : 105 - 113
  • [36] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
    Yaseen M. Arabi
    Anthony C. Gordon
    Lennie P. G. Derde
    Alistair D. Nichol
    Srinivas Murthy
    Farah Al Beidh
    Djillali Annane
    Lolowa Al Swaidan
    Abi Beane
    Richard Beasley
    Lindsay R. Berry
    Zahra Bhimani
    Marc J. M. Bonten
    Charlotte A. Bradbury
    Frank M. Brunkhorst
    Meredith Buxton
    Adrian Buzgau
    Allen Cheng
    Menno De Jong
    Michelle A. Detry
    Eamon J. Duffy
    Lise J. Estcourt
    Mark Fitzgerald
    Rob Fowler
    Timothy D. Girard
    Ewan C. Goligher
    Herman Goossens
    Rashan Haniffa
    Alisa M. Higgins
    Thomas E. Hills
    Christopher M. Horvat
    David T. Huang
    Andrew J. King
    Francois Lamontagne
    Patrick R. Lawler
    Roger Lewis
    Kelsey Linstrum
    Edward Litton
    Elizabeth Lorenzi
    Salim Malakouti
    Daniel F. McAuley
    Anna McGlothlin
    Shay Mcguinness
    Bryan J. McVerry
    Stephanie K. Montgomery
    Susan C. Morpeth
    Paul R. Mouncey
    Katrina Orr
    Rachael Parke
    Jane C. Parker
    Intensive Care Medicine, 2021, 47 : 867 - 886
  • [37] Effect of A Probiotic Preparation on Gut Microbiota in Critically Ill Septic Patients Admitted to Intensive Care Unit: A Pilot Randomized Controlled Trial
    Mahmoodpoor, Ata
    Ghaemi, Roya
    Shadvar, Kamran
    Saghaleini, Seied-Hadi
    Rahnemayan, Sama
    Shamekh, Ali
    Sanaie, Sarvin
    PHARMACEUTICAL SCIENCES, 2023, 29 (02) : 175 - 181
  • [38] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
    Arabi, Yaseen M.
    Gordon, Anthony C.
    Derde, Lennie P. G.
    Nichol, Alistair D.
    Murthy, Srinivas
    Al Beidh, Farah
    Annane, Djillali
    Al Swaidan, Lolowa
    Beane, Abi
    Beasley, Richard
    Berry, Lindsay R.
    Bhimani, Zahra
    Bonten, Marc J. M.
    Bradbury, Charlotte A.
    Brunkhorst, Frank M.
    Buxton, Meredith
    Buzgau, Adrian
    Cheng, Allen
    De Jong, Menno
    Detry, Michelle A.
    Duffy, Eamon J.
    Estcourt, Lise J.
    Fitzgerald, Mark
    Fowler, Rob
    Girard, Timothy D.
    Goligher, Ewan C.
    Goossens, Herman
    Haniffa, Rashan
    Higgins, Alisa M.
    Hills, Thomas E.
    Horvat, Christopher M.
    Huang, David T.
    King, Andrew J.
    Lamontagne, Francois
    Lawler, Patrick R.
    Lewis, Roger
    Linstrum, Kelsey
    Litton, Edward
    Lorenzi, Elizabeth
    Malakouti, Salim
    McAuley, Daniel F.
    McGlothlin, Anna
    Mcguinness, Shay
    McVerry, Bryan J.
    Montgomery, Stephanie K.
    Morpeth, Susan C.
    Mouncey, Paul R.
    Orr, Katrina
    Parke, Rachael
    Parker, Jane C.
    INTENSIVE CARE MEDICINE, 2021, 47 (08) : 867 - 886
  • [39] The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial
    Abulmeaty, Mahmoud M. A.
    Aljuraiban, Ghadeer S.
    Shaikh, Sumaya M.
    ALEid, Naif E.
    Mazrou, Lulwa R. Al
    Turjoman, Abdullah A.
    Aldosari, Mona S.
    Razak, Suhail
    El-Sayed, Mervat M.
    Areabi, Tahani M.
    Alsalafi, Rokia M.
    Al-Helio, Yasser S.
    Almutairy, Abdulrhman B.
    Molla, Haneen N.
    ANTIOXIDANTS, 2021, 10 (05)
  • [40] Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients
    Sivakorn, Chaisith
    Dechsanga, Jutamas
    Jamjumrus, Lawan
    Boonnak, Kobporn
    Schultz, Marcus J.
    Dorndorp, Arjen M.
    Phumratanaprapin, Weerapong
    Ratanarat, Ranistha
    Naorungroj, Thummaporn
    Wattanawinitchai, Patchrapa
    Siripoon, Tanaya
    Duangdee, Chatnapa
    Techarang, Tachpon
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (01): : 73 - 80